Tech Transfer Strategies: LGM Pharma and Rockwell Automation Insights

Early planning and data standardization improve pharmaceutical technology transfers, experts say. LGM Pharma and Rockwell Automation representatives discussed methods for streamlining drug manufacturing handoffs on August 8, 2025. Complex formulations and accelerated therapy development cycles create challenges for effective transfers. Deepak Thassu from LGM Pharma emphasized that gathering process knowledge early is crucial to avoid downstream problems. He noted that neglecting early data acquisition results in costly delays. Smriti Khera of Rockwell Automation highlighted the importance of structured data. Integrated control systems offer a foundation for data standardization during tech transfer. Khera explained that standardizing data formats allows manufacturing systems to directly read data, reducing errors. Integrated architectures facilitate superior communication and data accuracy between development and manufacturing teams. The professionals advocate for enhanced collaboration between contract manufacturers (CDMOs) and pharmaceutical sponsors. Transparent communication helps to align expectations and meet deadlines. A plant-wide control strategy is essential for modern pharmaceutical production. Thassu believes technology transfer must begin early, integrated with product development itself. Strategic planning throughout the entire drug development process is, therefore, necessary for success.